SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 196,908.71 |
Enterprise Value ($M) | 204,915.71 |
Book Value ($M) | 37,694.00 |
Book Value / Share | 21.72 |
Price / Book | 5.22 |
NCAV ($M) | -11,717.00 |
NCAV / Share | -6.75 |
Price / NCAV | -16.81 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.11 |
Return on Assets (ROA) | 0.08 |
Return on Equity (ROE) | 0.16 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.16 |
Current Ratio | 1.64 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 22,670.00 |
Assets | 73,214.00 |
Liabilities | 34,387.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 40,109.00 |
Operating Income | 6,693.00 |
Net Income | 5,723.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 7,261.00 |
Cash from Investing | -3,133.00 |
Cash from Financing | -7,091.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 9.01 | 0.62 | |
13G/A | BlackRock Inc. | 7.70 | -3.92 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
396,853 | 3,292,402 | 12.05 | |
569,944 | 7,533,356 | 7.57 | |
721,057 | 7,770,829 | 9.28 | |
640,578 | 6,622,414 | 9.67 | |
(click for more detail) |
Similar Companies | |
---|---|
ABBV – AbbVie Inc. | ADCT – ADC Therapeutics SA |
ANRO – Alto Neuroscience, Inc. |